Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
May 10 FBIO Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates
May 10 LDOS 5 Stocks Trading Near 52-Week High With More Upside Potential
May 10 FUSN Fusion Pharmaceuticals doses first subject in prostate cancer trial
May 10 GH Guardant Health, Inc. (GH) Q1 2024 Earnings Call Transcript
May 9 GH Compared to Estimates, Guardant Health (GH) Q1 Earnings: A Look at Key Metrics
May 9 GH Guardant Health (GH) Reports Q1 Loss, Tops Revenue Estimates
May 9 GH Guardant Health Non-GAAP EPS of -$0.46 beats by $0.27, revenue of $168.5M beats by $18.43M
May 9 FUSN Fusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate Cancer
May 9 GH Guardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
May 9 GMED GMED or PEN: Which Is the Better Value Stock Right Now?
May 9 IMUX Immunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript
May 9 GMED Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run Continue?
May 9 GMED Surgical robots are ‘gift that will keep on giving,’ ortho firms say
May 9 IMUX We Think Immunic (NASDAQ:IMUX) Needs To Drive Business Growth Carefully
May 9 ICLR ICON releases its ICON Cares 2023 Report
May 9 GMED Three Growth Companies With High Insider Ownership And 36% Earnings Growth
May 8 GH Guardant Health Q1 2024 Earnings Preview
May 8 IMUX Immunic, Inc. (IMUX) Q1 2024 Earnings Call Transcript
May 8 LDOS Leidos (LDOS) is a Great Momentum Stock: Should You Buy?
May 8 GMED Globus Medical, Inc. (NYSE:GMED) Q1 2024 Earnings Call Transcript
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags